Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?

Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?

Glaucoma is a common ocular neurodegenerative disease characterized by the progressive loss of retinal ganglion cells and their axons. It is the most common cause of irreversible blindness. With an increasing number of glaucoma patients and disease progression despite treatment, it is paramount to d...

Full description

Bibliographic Details
Main Authors: Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna-Sophie Thein, Jens Rovelt, Barbara Cvenkel, Pete A. Williams, Augusto Azuara-Blanco, Miriam Kolko
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Neuroscience
Subjects:
glaucoma
GLP-1 receptor agonists
antidiabtics
ophthalmology
neuroprotection
neurodegenerative diseases
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2022.824054/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2022.824054/full

Similar Items